Subscribe: Stocks Under $10
Preview: Stocks Under $10 Stocks Under $10 Stocks Under $10 allows individual investors to expand their portfolios and increase potential profits by investing in lower-priced, undervalued stocks. Service includes email alerts and 24/7 access to a model portfolio.

Copyright: 1996-2017, Inc.

Exiting Our Position in This Homebuilder

Fri, 28 Apr 2017 14:52 GMT

We'll sell all of our CAA shares as the stock is outside the portfolio's parameters.

Stocks Under $10: Hearing Something Interesting About SiriusXM

Fri, 28 Apr 2017 12:00 GMT

Stephen “Sarge” Guilfoyle thinks SiriusXM Holdings sounds good around this level.

Cutting Sonus' Price Target, and a Reminder on CalAtlantic Homes

Thu, 27 Apr 2017 11:35 GMT

Sonus Networks posted less disappointed than expected earnings.

Zix Dances to a First-Quarter Beat

Wed, 26 Apr 2017 14:48 GMT

Plus, comments on Amplify Snack Brands in light of Pepsi's results.

Stocks Under $10: How About Hudson Technologies?

Tue, 25 Apr 2017 12:00 GMT

Stephen "Sarge" Guilfoyle lays out out the argument that investors may find a winner in Hudson Technologies.

Stocks Under $10 Weekly Summary

Mon, 24 Apr 2017 21:17 GMT

We exited one position and downgraded another as earnings season heated up.

Stocks Under $10: Who’s that? It’s Avon calling

Fri, 21 Apr 2017 12:00 GMT

'Sarge' Guilfoyle says that if it's possible to sniff out when a beaten-down stock can make a positive change, Avon could be it.

Downgrading TherapeuticsMD

Wed, 19 Apr 2017 14:27 GMT

Company commentary this morning adds layer of uncertainty, which warrants being extra cautious.

Exiting a Financial Position

Tue, 18 Apr 2017 15:40 GMT

We are selling our holdings in Synovus Financial on today's strength. Plus, an update on TherapeuticsMD.

Stocks Under $10: Introducing ‘Sarge’ Guilfoyle

Tue, 18 Apr 2017 11:00 GMT

Stephen “Sarge” Guilfoyle is our newest contributor to Stocks Under $10. And today he has an idea for you on how to make a little lunch money.

Stocks Under $10 Weekly Summary

Mon, 17 Apr 2017 20:39 GMT

We added a new name to the portfolio as the market took a breather in a shortened trading week.

We're Downgrading Synovus

Thu, 13 Apr 2017 13:38 GMT

Our concern about slowing loan growth in the banking sector has led us to reduce our rating on Synovus Financial to a Three from a Two.

Evaluating Abraxas and the Oil Market

Wed, 12 Apr 2017 14:09 GMT

A look at how current market dynamics are affecting our outlook for AXAS.

TherapeuticsMD Falls More, but We're Keeping It for Now

Tue, 11 Apr 2017 18:59 GMT

We'll wait to see how firm deals with FDA letter.

Amplifying on Why We Like Amplify Snacks

Tue, 11 Apr 2017 13:23 GMT

We added shares of this snack food maker to the portfolio to capitalize on the shifting consumer preference for foods that are good for you.

Adding a Snack Name to the Portfolio

Tue, 11 Apr 2017 12:56 GMT

Amplify Snacks is a stealth stock with a lot of potential.

Stocks Under $10 Weekly Summary

Mon, 10 Apr 2017 20:18 GMT

Chris Versace runs down the portfolio.

TherapeuticsMD Whacked on FDA News

Mon, 10 Apr 2017 13:08 GMT

The company received a letter from the Food and Drug Administration involving deficiencies of an application for a key drug candidate.

The Jobs Report Is Worrying for Consumer Spending

Fri, 07 Apr 2017 14:08 GMT

Our two homebuilding-related stocks depend on the health of consumers.

Examining Facebook's Digital Payments Move

Thu, 06 Apr 2017 16:30 GMT

The current wave includes our new position, USA Technologies.